AQR Capital Management
TNXP icon

AQR Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

AQR Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
882,595
+721,387
+447% +$9.31M ﹤0.01% 1496
2026
Q1 		$2.22M Buy
161,208
+141,188
+705% +$2.17M ﹤0.01% 2279
2025
Q4 		$313K Buy
+20,020
New +$369K ﹤0.01% 3150
2022
Q1 		– Sell
-2
Closed -$366K – 2294
2021
Q4 		$366K Buy
+2
New +$636K ﹤0.01% 1925
2021
Q3 		– Hold
0
– – – 2224
2021
Q2 		– Hold
0
– – – 2076
2015
Q1 		– Hold
0
– -$89K – 2309
2014
Q4 		– Hold
0
– – – 2460
2014
Q3 		– Hold
0
– – – 2455

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AQR Capital Management's TNXP Position: Q2 2026 in Review

AQR Capital Management increased its Tonix Pharmaceuticals (TNXP) stake by 447% in Q2 2026, buying an estimated $9.31M and bringing the position to 882,595 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

AQR Capital Management first reported a position in TNXP in Q4 2021 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • AQR Capital Management held 882,595 shares of Tonix Pharmaceuticals worth $11.3M as of Q2 2026.
  • AQR Capital Management bought 721,387 Tonix Pharmaceuticals shares in Q2 2026, an estimated $9.31M.
  • Tonix Pharmaceuticals made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #1496 holding.
  • AQR Capital Management first reported a position in Tonix Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.